Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
出版年份 2019 全文链接
标题
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
作者
关键词
Antibody-mediated rejection, Clazakizumab, Donor-specific antibody, Interleukin-6, Kidney transplantation, Monoclonal antibody
出版物
Trials
Volume 20, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-01-11
DOI
10.1186/s13063-018-3158-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
- (2018) M. Haas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development
- (2017) Chris Wiebe et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
- (2017) Farsad Eskandary et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study
- (2017) Daniel Aletaha et al. LANCET
- Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection
- (2017) Stanley C. Jordan et al. TRANSPLANTATION
- Torque Teno Virus Load—Inverse Association With Antibody-Mediated Rejection After Kidney Transplantation
- (2017) Martin Schiemann et al. TRANSPLANTATION
- Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial
- (2016) S. Kulkarni et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Molecular assessment of disease states in kidney transplant biopsy samples
- (2016) Philip F. Halloran et al. Nature Reviews Nephrology
- The Efficacy and Safety of Clazakizumab, an Anti-Interleukin-6 Monoclonal Antibody, in a Phase IIb Study of Adults With Active Psoriatic Arthritis
- (2016) Philip J. Mease et al. Arthritis & Rheumatology
- Positive Crossmatch Kidney Transplant Recipients Treated With Eculizumab: Outcomes Beyond 1 Year
- (2015) L. D. Cornell et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The Synergistic Effect of Class II HLA Epitope-Mismatch and Nonadherence on Acute Rejection and Graft Survival
- (2015) C. Wiebe et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Interleukin-6 as a Therapeutic Target
- (2015) J.-F. Rossi et al. CLINICAL CANCER RESEARCH
- Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody-mediated rejection: a pilot study
- (2015) Thomas Bachelet et al. CLINICAL TRANSPLANTATION
- The Efficacy and Safety of Subcutaneous Clazakizumab in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results From a Multinational, Phase IIb, Randomized, Double-Blind, Placebo/Active-Controlled, Dose-Ra
- (2015) Michael E. Weinblatt et al. Arthritis & Rheumatology
- GFR Decline as an End Point in Trials of CKD: A Viewpoint From the FDA
- (2014) Aliza Thompson et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches
- (2014) A. Djamali et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
- (2014) Josef Coresh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High Dose Intravenous Immunoglobulin Therapy for Donor-Specific Antibodies in Kidney Transplant Recipients With Acute and Chronic Graft Dysfunction
- (2014) James E. Cooper et al. TRANSPLANTATION
- Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy
- (2013) Iwijn De Vlaminck et al. CELL
- Donor-specific HLA antibodies and renal allograft failure
- (2013) Alexandre Loupy et al. Nature Reviews Nephrology
- A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate
- (2012) P Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Proteasome inhibitor-based therapy for antibody-mediated rejection
- (2012) R. Carlin Walsh et al. KIDNEY INTERNATIONAL
- IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up
- (2012) Heiko Billing et al. TRANSPLANT INTERNATIONAL
- Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
- (2011) J. Sellarés et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
- (2011) Trevor J Bayliss et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Rituximab and Intravenous Immunoglobulin Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection
- (2009) Thomas Fehr et al. TRANSPLANTATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started